Letters
Conflicts of interest in guideline development committees
A risk based model for managing conflicts of interest in clinical guidelines can’t fix a broken system
BMJ 2023; 380 doi: https://doi.org/10.1136/bmj.p249 (Published 02 February 2023) Cite this as: BMJ 2023;380:p249
- Alain Braillon, retired senior consultant
- Amiens, France
- braillon.alain{at}gmail.com
Parker and Bero’s risk based model for minimising conflicts of interest in clinical guideline development is well intended but the problem is a systemic one.1
Firstly, the main conflict of interest is that we are healthcare providers belonging to a market society. We therefore promote the medicalisation of life over tackling the social determinants …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.